Biomass-derived Carbon Dots from Ningxia Goji Berries for Targeted Alleviation of Ulcerative Colitis via ROS Scavenging and Microbiota Regulation

Background: Biomass-derived carbon dots (CDs) combine nanoscale optical and redox properties with the chemical diversity of botanical precursors. Their oral use in ulcerative colitis (UC) is attractive because oxidative stress, epithelial barrier failure, immune dysregulation, and microbiota disturbance reinforce one another. Ningxia goji berry (Lycium barbarum L.) is a regionally important medicine–food resource, but its value as a CD precursor must be separated from the pharmacology of the unprocessed fruit. Content: This critical review integrates evidence from biomass-derived CDs, herbal CD nanozymes, intestinal redox biology, microbiome research, and adjacent nanomaterial sciences. Direct studies of oral CDs in colitis demonstrate that selected formulations can modulate reactive oxygen and nitrogen species, inflammatory signaling, barrier integrity, and microbial ecology in preclinical models. Evidence specifically establishing Ningxia goji-derived CDs as a targeted UC therapy remains limited; the title therefore defines a testable therapeutic proposition rather than a clinically validated conclusion. We examine precursor authentication, hydrothermal carbonization, surface-group conservation, colonic delivery, antioxidant enzyme-like activity, microbiota causality, safety, reproducibility, and regulatory readiness. Particular attention is given to distinguishing ROS scavenging from indiscriminate redox suppression and microbiota restoration from nonspecific changes in taxonomic relative abundance. Conclusions: A credible goji-CD platform should be developed as a chemically defined, quality-controlled oral nanomaterial, not as a simple carbonized extract. Mechanistic claims require orthogonal redox assays, spatial evidence of colonic exposure, germ-free or microbiota-transfer validation, dose–response toxicology, and comparison with standard therapies. The proposed roadmap provides a rigorous basis for converting regional biomass into a reproducible UC candidate while avoiding unsupported efficacy claims.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-18
DOI
https://doi.org/10.5281/zenodo.24332835
Primary Topic
Carbon and Quantum Dots Applications
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Biomass-derived Carbon Dots from Ningxia Goji Berries for Targeted Alleviation of Ulcerative Colitis via ROS Scavenging and Microbiota Regulation

Weikaixin Kong, Hao Sun, Yuanyin Teng, Xinling Li et al.
5 links
Zenodo (CERN European Organization for Nuclear Research)
Carbon and Quantum Dots Applications
article

Biomass-derived Carbon Dots from Ningxia Goji Berries for Targeted Alleviation of Ulcerative Colitis via ROS Scavenging and Microbiota Regulation

Weikaixin Kong, Hao Sun, Yuanyin Teng, Xinling Li, Keyang Xu, Weichu Tang
article en

Abstract

Background: Biomass-derived carbon dots (CDs) combine nanoscale optical and redox properties with the chemical diversity of botanical precursors. Their oral use in ulcerative colitis (UC) is attractive because oxidative stress, epithelial barrier failure, immune dysregulation, and microbiota disturbance reinforce one another. Ningxia goji berry (Lycium barbarum L.) is a regionally important medicine–food resource, but its value as a CD precursor must be separated from the pharmacology of the unprocessed fruit. Content: This critical review integrates evidence from biomass-derived CDs, herbal CD nanozymes, intestinal redox biology, microbiome research, and adjacent nanomaterial sciences. Direct studies of oral CDs in colitis demonstrate that selected formulations can modulate reactive oxygen and nitrogen species, inflammatory signaling, barrier integrity, and microbial ecology in preclinical models. Evidence specifically establishing Ningxia goji-derived CDs as a targeted UC therapy remains limited; the title therefore defines a testable therapeutic proposition rather than a clinically validated conclusion. We examine precursor authentication, hydrothermal carbonization, surface-group conservation, colonic delivery, antioxidant enzyme-like activity, microbiota causality, safety, reproducibility, and regulatory readiness. Particular attention is given to distinguishing ROS scavenging from indiscriminate redox suppression and microbiota restoration from nonspecific changes in taxonomic relative abundance. Conclusions: A credible goji-CD platform should be developed as a chemically defined, quality-controlled oral nanomaterial, not as a simple carbonized extract. Mechanistic claims require orthogonal redox assays, spatial evidence of colonic exposure, germ-free or microbiota-transfer validation, dose–response toxicology, and comparison with standard therapies. The proposed roadmap provides a rigorous basis for converting regional biomass into a reproducible UC candidate while avoiding unsupported efficacy claims.

Zenodo (CERN European Organization for Nuclear Research)
Macau University of Science and Technology (MO), Georgia Institute of Technology (US), Emory University (US), The Wallace H. Coulter Department of Biomedical Engineering (US), University College London (GB), Zhejiang University (CN), Aalto University (FI)
Good health and well-being
Carbon and Quantum Dots Applications
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon